MedPath

Pilot study: schema mindfulness group training versus self-image module group training

Completed
Conditions
personality disorder
personality problems
10034726
Registration Number
NL-OMON39329
Lead Sponsor
GGZ Delfland (Delft)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
36
Inclusion Criteria

Patients need to have as primary diagnosis on axis II a personality disorder. Features of a personality disorder instead of a fullblown personality disorder will also be included.

Exclusion Criteria

psychotic features, substance abuse, untreated ADHD, bipolar I disorder, IQ lower then 80 points.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Main Parameter: The main parameter in this study is the score of the SCL-90.<br /><br>The expectation is that patients with personality problems benefit more from<br /><br>schemafocused mindfulness training group than in the module self-image training<br /><br>group. The score on the SCL-90 would have to decrease more in the module<br /><br>schemafocused mindfulness training group than in the module self-image group<br /><br>training. This is considered to be a moderate effect: 0.25.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcome measures:<br /><br>scores on the YSQ, SMI I, MAAS and RSES.<br /><br>The Personality Severity Index (PSI) (part of the SCL-90) during decreases more<br /><br>during module schemafocused mindfulness than during module self-image.<br /><br>The intensity of the schema modes and schemas decreasesmore during module<br /><br>schemafocused mindfulness than during module self-image.<br /><br>The degree of mindfulness increases stronger during module schemafocused<br /><br>mindfulness than during module self-image.<br /><br>The self-image enhances more during module self-image than during module<br /><br>schemafocused mindfulness</p><br>
© Copyright 2025. All Rights Reserved by MedPath